Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Synthesis and biological activity of 5-aza-ellipticine derivatives
  2. Moody, D. L.; Dyba, M.; Kosakowska-Cholody, T.; Tarasova, N. I.; Michejda, C. I.
  3. Bioorganic & Medicinal Chemistry Letters. 2007, Apr; 17(8): 2380-2384.
  1. 2.   Evaluating chemical structure similarity as an indicator of cellular growth inhibition
  2. Wallqvist, A.; Huang, R. L.; Thanki, N.; Covell, D. G.
  3. Journal of Chemical Information and Modeling. 2006, JAN-FEB; 46(1): 430-437.
  1. 3.   The development of VIP-ellipticine conjugates
  2. Moody, T. W.; Czerwinski, G.; Tarasova, N. I.; Moody, D. L.; Michejda, C. J.
  3. Regulatory Peptides. 2004, DEC 15; 123(1-3): 187-192.
  1. 4.   VIP-ellipticine derivatives inhibit the growth of breast cancer cells
  2. Moody, T. W.; Czerwinski, G.; Tarasova, N. I.; Michejda, C. J.
  3. Life Sciences. 2002 71(9): 1005-1014.
  1. 5.   Mining the National Cancer Institute's tumor-screening database: Identification of compounds with similar cellular activities
  2. Rabow, A. A.; Shoemaker, R. H.; Sausville, E. A.; Covell, D. G.
  3. Journal of Medicinal Chemistry. 2002 45(4): 818-840.
  1. 6.   Characterization of anticancer agents by their growth inhibitory activity and relationships to mechanism of action and structure
  2. Keskin, O.; Bahar, I.; Jernigan, R. L.; Beutler, J. A.; Shoemaker, R. H.; Sausville, E. A.; Covell, D. G.
  3. Anti-Cancer Drug Design. 2000 15(2): 79-98.
  1. 7.   A gene expression database for the molecular pharmacology of cancer
  2. Scherf, U.; Ross, D. T.; Waltham, M.; Smith, L. H.; Lee, J. K.; Tanabe, L.; Kohn, K. W.; Reinhold, W. C.; Myers, T. G.; Andrews, D. T.; Scudiero, D. A.; Eisen, M. B.; Sausville, E. A.; Pommier, Y.; Botstein, D.; Brown, P. O.; Weinstein, J. N.
  3. Nature Genetics. 2000 24(3): 236-244.
  1. 8.   In Vitro Neurotoxicity of the Antitumor Agent 9-Methoxy-N-2-Methylellipticinium Acetate (Mmea) - Role of Brain Cytochrome P-450 (Vol 18, Pg 97, 1997)
  2. Sriram, K.; Boyd, M. R.; Vistica, D. T.; Ravindranath, V.
  3. Neurotoxicology. 1998 19(1): 167.
  1. 9.   Rational design of peptide receptor targeted anti-tumor drugs. Ellipticine derivatives of gastrin and cholecystokinin
  2. Czerwinski, G.; Tarasova, N. I.; Michejda, C. J.
  3. Annual Meeting of the American Association for Cancer Research. 1997, 38 A2900.
  1. 10.   In Vitro Neurotoxicity of the Antitumor Agent 9-Methoxy-N-2-Methylellipticinium Acetate (Mmea) - Role of Brain Cytochrome P-450
  2. Sriram, K.; Boyd, M. R.; Vistica, D. T.; Ravindranath, V.
  3. Neurotoxicology. 1997 18(1): 97-104.
  1. 11.   Histological, Histochemical and Autoradiographic Evidence of in Vitro Neurotoxic Effects of the Novel Antitumor Agent, 9-Methoxy-N-2-Methylellipticinium Acetate
  2. Shankar, L.; Ravindranath, V.; Boyd, M. R.; Vistica, D. T.; Shankar, S. K.
  3. Neurotoxicology. 1997 18(1): 89-95.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel